Palisade Bio (PALI) EBITDA Margin (2011 - 2023)
Palisade Bio (PALI) reported EBITDA Margin of 1011.6% for Q1 2023, up 99.43% on a QoQ basis from 176623.48% in Q4 2020.
Palisade Bio (PALI) has 11 years of EBITDA Margin data on file, last reported at 1011.6% in Q1 2023.
- Quarterly EBITDA Margin changed N/A year-over-year to 1011.6% in Q1 2023, while the trailing twelve-month figure through Dec 2023 was 5228.0% (changed N/A YoY) and the FY2023 annual result came in at 5228.0%, changed N/A from the prior year.
- EBITDA Margin rose to 1011.6% in Q1 2023 per PALI's latest filing, from 176623.48% in the prior quarter.
- Across five years, EBITDA Margin topped out at 1011.6% in Q1 2023 and bottomed at 176623.48% in Q4 2020.
- The 3-year median for EBITDA Margin is 81444.8% (2019), against an average of 85473.82%.
- The widest annual swing landed in 2019, when EBITDA Margin jumped 252640 bps; it then tumbled 9517868 bps in 2020.
- Tracing PALI's EBITDA Margin over 3 years: stood at 81444.8% in 2019, then tumbled by 117 bps to 176623.48% in 2020, then soared by 99 bps to 1011.6% in 2023.
- Per Business Quant, the three latest PALI EBITDA Margin figures stand at 1011.6% (Q1 2023), 176623.48% (Q4 2020), and 92745.68% (Q3 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -1,011.60% |
| Dec 31, 2020 | -176,623.48% |
| Sep 30, 2020 | -92,745.68% |
| Jun 30, 2020 | -78,038.36% |
| Mar 31, 2020 | -125,850.17% |
| Dec 31, 2019 | -81,444.80% |
| Sep 30, 2019 | -70,705.40% |
| Jun 30, 2019 | -18,215.53% |
| Mar 31, 2019 | -124,629.40% |
| Dec 31, 2018 | -12,854.52% |
| Sep 30, 2018 | -73,231.80% |
| Jun 30, 2018 | -248.97% |
| Mar 31, 2018 | -85,874.12% |
| Dec 31, 2017 | -1,313.06% |
| Sep 30, 2017 | -5,391.52% |
| Jun 30, 2017 | -185,983.04% |
| Mar 31, 2017 | -302,697.00% |
| Dec 31, 2016 | -61,704.99% |
| Sep 30, 2016 | -208,810.48% |
| Jun 30, 2016 | -153,969.64% |
| Mar 31, 2016 | -264,302.24% |
| Dec 31, 2015 | -190,632.00% |
| Sep 30, 2015 | -225,593.72% |
| Jun 30, 2015 | -217,922.20% |
| Mar 31, 2015 | -158,141.24% |
| Dec 31, 2014 | -99,463.46% |
| Sep 30, 2014 | -82,134.90% |
| Jun 30, 2014 | -70,224.76% |
| Mar 31, 2014 | -124,235.69% |
| Dec 31, 2013 | -110,502.92% |
| Sep 30, 2013 | -145,359.44% |
| Jun 30, 2013 | -129,424.08% |
| Mar 31, 2013 | -2,821.25% |
| Dec 31, 2012 | -109,073.04% |
| Sep 30, 2012 | -1,512.10% |
| Jun 30, 2012 | -3,050.57% |
| Mar 31, 2012 | -1,576.46% |
| Dec 31, 2011 | -892.05% |
| Sep 30, 2011 | -3,116.57% |